Company BioSig Technologies Inc Nasdaq
Equities
US09073N2018
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
BioSig
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -35.15% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -35.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frederick Hrkac
CEO | Chief Executive Officer | 58 | Feb. 26 |
Lora Mikolaitis
ADM | Chief Administrative Officer | 51 | 09-02-23 |
Chief Tech/Sci/R&D Officer | 74 | 09-02-23 | |
Investor Relations Contact | - | 19-10-28 | |
Katie Freshwater
SAM | Sales & Marketing | - | 22-09-30 |
Zachary Koch
PRN | Corporate Officer/Principal | - | 21-12-31 |
Ewald Riechert
LAW | General Counsel | - | - |
Brenda Castrodad
HRO | Human Resources Officer | - | 21-02-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 74 | 09-02-23 | |
Frederick Hrkac
CEO | Chief Executive Officer | 58 | Feb. 26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,334,636 | 7,228,446 ( 77.44 %) | 0 | 77.44 % |
Stock B | 0 | 105 | 0 | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.69% | 46.84B | |
+4.66% | 42.64B | |
+15.12% | 29.09B |